Bavarian Nordic sees potential to ramp up mpox vaccine capacity

COPENHAGEN, Sept 12 (Reuters) – Bavarian Nordic said on Thursday it could supply up to 13 million doses of its mpox vaccine by the end of 2025.

The Danish biotech company added it had identified a potential additional supply of 50 million doses that could be supplied within the next 12-18 months, subject to regulatory approvals and market demand. (Reporting by Stine Jacobsen, editing by Essi Lehto)

(c) Copyright Thomson Reuters 2024. Click For Restrictions – https://agency.reuters.com/en/copyright.html